Neurim Pharmaceuticals will market its new drugs through strategic alliances with reputable marketing and distribution partners on whose marketing expertise we are rely.

Neurim is currently targeting mainly the European, North American and Japanese markets.

Neurim has so far established marketing and sales agreements with TEVA, LUNDBECK, NYCOMED, SIGMA, DKSH:

We are actively seeking strategic alliances for non-European markets.

 Please feel free to contact us: